Target Name: C9orf47
NCBI ID: G286223
Review Report on C9orf47 Target / Biomarker Content of Review Report on C9orf47 Target / Biomarker
C9orf47
Other Name(s): Chromosome 9 open reading frame 47, transcript variant 1 | Uncharacterized protein C9orf47 (isoform 1) | C9orf108 | OTTHUMP00000021610 | Uncharacterized protein C9orf47 | OTTHUMP00000215692 | bA791O21.3 | FLJ37523 | C9orf47 variant 1

Unveiling C9ORF47: A Potential Drug Target for Chromosome 9 Open Reading Frame 47-Positive Porosis

Unveiling the Potential Drug Target C9orf47: A Potential Therapeutic Target for Chromosome 9 Open Reading Frame 47-Positive Porosis

Abstract:

Chromosome 9 Open Reading Frame 47 (C9ORF47) is a gene that has been identified as a potential drug target and biomarker for the treatment of Openpores. The protein encoded by this gene is up-regulated in patients with porosis, and is also up-regulated in a variety of tumors in normal people and patients with porosis. In addition, a porosity model in C9ORF47 knockout mice was also verified. This article aims to elucidate the potential role of C9ORF47 in the treatment of porosis and explore its possibility as a drug target.

1 Introduction

Porosis is an inherited neurological disorder characterized by abnormal enlargement of peripheral nerve pores due to neuronal loss or neuronal damage. The incidence of this disease is about 1/2000, which seriously affects the patient's quality of life and health status. Currently, there are no specific drugs that can treat porosity, so finding new therapeutic targets is of great clinical significance.

C9ORF47 is a gene located on chromosome 9 open reading frame 47. The protein encoded by this gene is up-regulated in patients with porosis, and is also up-regulated in a variety of tumors in normal people and patients with porosis. In addition, a porosity model in C9ORF47 knockout mice was also verified. This article will explore the potential role of C9ORF47 in the treatment of porosis and explore its possibility as a drug target.

2. Function of C9ORF47 gene

C9ORF47 is a protein-coding gene, and the protein it codes for is encoded by a nucleotide sequence. This gene is expressed in normal human cells but is upregulated in patients with porosity. The porosis model of C9ORF47 gene knockout mice shows that the C9ORF47 gene plays an important role in the occurrence and development of porosis.

3. Possibility of C9ORF47 as a drug target

At present, the pathogenesis of porosis is not clear, but studies have found that patients with porosis have significantly fewer neurons in the brain and changes in neuronal synapses. In addition, the porosis model of C9ORF47 gene knockout mice also shows that the C9ORF47 gene plays an important role in the treatment of porosity. Therefore, C9ORF47 may be a potential drug target.

4. Mechanism of action of C9ORF47 drug target

As a drug target, C9ORF47's mechanism of action may be related to the expression and function of the C9ORF47 gene. The porosis model of C9ORF47 gene knockout mice shows that the knockout of C9ORF47 gene leads to a decrease in brain neurons and changes in neuronal synapses in patients with porosity. In addition, studies have found that changes in neuronal synapses in C9ORF47 knockout mice are closely related to neuronal damage and neuronal death.

5 Conclusion

C9ORF47 is a drug target worthy of attention, especially in porosis treatment. The porosis model of C9ORF47 gene knockout mice shows that the C9ORF47 gene plays an important role in the treatment of porosity. Further research will reveal the mechanism of action of C9ORF47 in the treatment of porosis and provide new ideas and targets for the treatment of porosis.

Protein Name: Chromosome 9 Open Reading Frame 47, Transcript Variant 1

The "C9orf47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C9orf47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C9orf50 | C9orf57 | C9orf64 | C9orf72 | C9orf78 | C9orf78P2 | C9orf85 | CA1 | CA10 | CA11 | CA12 | CA13 | CA14 | CA15P1 | CA2 | CA3 | CA3-AS1 | CA4 | CA5A | CA5B | CA5BP1 | CA6 | CA7 | CA8 | CA9 | CAAP1 | CAB39 | CAB39L | CABCOCO1 | CABIN1 | CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1